FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal
[ad_1] The Food and Drug Administration (FDA) on Friday introduced it handed down an emergency use authorization for Eli Lilly and Company’s bebtelovimab, a monoclonal antibody therapy for COVID-19. The drug is meant for the therapy of gentle to average COVID-19, the sickness attributable to the CCP (Chinese Communist Party) virus in sufferers aged 12…
Read More “FDA Authorizes Emergency Use for Monoclonal Antibody Drug Amid $720 Million Deal” »